Selected article for: "logistic regression and random forest"

Author: Dun, C.; Walsh, C.; Bae, S.; Adalja, A.; Toner, E.; Lash, T. A.; Hashim, F.; Paturzo, J.; Segev, D. L.; Makery, M. A.
Title: A Machine Learning Study of 534,023 Medicare Beneficiaries with COVID-19: Implications for Personalized Risk Prediction
  • Cord-id: 1nth9b9u
  • Document date: 2020_10_30
  • ID: 1nth9b9u
    Snippet: Background: Global demand for a COVID-19 vaccine will exceed the initial limited supply. Identifying individuals at highest risk of COVID-19 death may help allocation prioritization efforts. Personalized risk prediction that uses a broad range of comorbidities requires a cohort size larger than that reported in prior studies. Methods: Medicare claims data was used to identify patients age 65 years or older with diagnosis of COVID-19 between April 1, 2020 and August 31, 2020. Demographic characte
    Document: Background: Global demand for a COVID-19 vaccine will exceed the initial limited supply. Identifying individuals at highest risk of COVID-19 death may help allocation prioritization efforts. Personalized risk prediction that uses a broad range of comorbidities requires a cohort size larger than that reported in prior studies. Methods: Medicare claims data was used to identify patients age 65 years or older with diagnosis of COVID-19 between April 1, 2020 and August 31, 2020. Demographic characteristics, chronic medical conditions, and other patient risk factors that existed before the advent of COVID-19 were identified. A random forest model was used to empirically explore factors associated with COVID-19 death. The independent impact of factors identified were quantified using multivariate logistic regression with random effects. Results: We identified 534,023 COVID-19 patients of whom 38,066 had an inpatient death. Demographic characteristics associated with COVID-19 death included advanced age (85 years or older: aOR: 2.07; 95% CI, 1.99-2.16), male sex (aOR, 1.88; 95% CI, 1.82-1.94), and non-white race (Hispanic: aOR, 1.74; 95% CI, 1.66-1.83). Leading comorbidities associated with COVID-19 mortality included sickle cell disease (aOR, 1.73; 95% CI, 1.21-2.47), chronic kidney disease (aOR, 1.32; 95% CI, 1.29-1.36), leukemias and lymphomas (aOR, 1.22; 95% CI, 1.14-1.30), heart failure (aOR, 1.19; 95% CI, 1.16-1.22), and diabetes (aOR, 1.18; 95% CI, 1.15-1.22). Conclusions: We created a personalized risk prediction calculator to identify candidates for early vaccine and therapeutics allocation (www.predictcovidrisk.com). These findings may be used to protect those at greatest risk of death from COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute myocardial infarction and logistic model: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute myocardial infarction and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute myocardial infarction and low prevalence: 1, 2, 3, 4
    • adjusted multivariate model and logistic model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • adjusted multivariate model and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • liver disease and logistic model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • liver disease and logistic multilevel: 1, 2
    • liver disease and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • liver disease and low prevalence: 1, 2, 3, 4, 5
    • liver disease and low sensitivity: 1, 2
    • liver disease and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • liver disease and lung cancer obesity: 1
    • liver disease and lung cancer obesity cardiovascular disease: 1
    • liver disease and lymphoma leukemia: 1, 2, 3, 4, 5
    • liver obesity and logistic model: 1, 2, 3
    • liver obesity and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • liver obesity and low prevalence: 1
    • liver obesity and lung cancer: 1, 2, 3
    • liver obesity and lung cancer obesity: 1, 2